Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
HighVista Strategies LLC (CIK 1335325) reported $362.2M across 153 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: DBC ($30.6M, 8.45%), ABVX ($12.6M, 3.48%), PRAX ($8.5M, 2.34%), COGT ($7.6M, 2.09%), SYRE ($7.4M, 2.04%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DBC | INVESCO DB COMMDY INDX TRCK | $30.6M | 8.45% | 1.1M | Hold |
| 2 | ABVX | ABIVAX SA | $12.6M | 3.48% | 113,254 | Added |
| 3 | PRAX | PRAXIS PRECISION MEDICINES I | $8.5M | 2.34% | 26,323 | Added |
| 4 | COGT | COGENT BIOSCIENCES INC | $7.6M | 2.09% | 197,051 | Trimmed |
| 5 | SYRE | SPYRE THERAPEUTICS INC | $7.4M | 2.04% | 146,264 | Trimmed |
| 6 | PCVX | VAXCYTE INC | $7.2M | 2.00% | 124,647 | Added |
| 7 | RVMD | REVOLUTION MEDICINES INC | $6.7M | 1.86% | 69,309 | Trimmed |
| 8 | TERN | TERNS PHARMACEUTICALS INC | $6.0M | 1.66% | 114,307 | Trimmed |
| 9 | GPCR | STRUCTURE THERAPEUTICS INC | $6.0M | 1.65% | 123,909 | Trimmed |
| 10 | NUVL | NUVALENT INC | $5.8M | 1.60% | 56,602 | Trimmed |
| 11 | IMVT | IMMUNOVANT INC | $5.6M | 1.54% | 225,139 | Added |
| 12 | SLNO | SOLENO THERAPEUTICS INC | $5.5M | 1.53% | 165,227 | Added |
| 13 | TYRA | TYRA BIOSCIENCES INC | $5.0M | 1.39% | 131,304 | Added |
| 14 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.9M | 1.35% | 352,085 | Added |
| 15 | AMZN | AMAZON COM INC | $4.7M | 1.29% | 22,397 | Added |
| 16 | LB PHARMACEUTICALS INC | $4.3M | 1.18% | 173,595 | Added | |
| 17 | RLAY | RELAY THERAPEUTICS INC | $4.2M | 1.16% | 421,881 | Trimmed |
| 18 | INSM | INSMED INC | $4.0M | 1.10% | 24,316 | Trimmed |
| 19 | NVDA | NVIDIA CORPORATION | $3.9M | 1.08% | 22,420 | Added |
| 20 | CYTK | CYTOKINETICS INC | $3.9M | 1.07% | 58,643 | Trimmed |
| 21 | ORKA | ORUKA THERAPEUTICS INC | $3.9M | 1.07% | 78,911 | New |
| 22 | LQDA | LIQUIDIA CORPORATION | $3.8M | 1.04% | 99,744 | Trimmed |
| 23 | OCUL | OCULAR THERAPEUTIX INC | $3.7M | 1.03% | 441,573 | Added |
| 24 | TARS | TARSUS PHARMACEUTICALS INC | $3.7M | 1.02% | 52,464 | Trimmed |
| 25 | BBIO | BRIDGEBIO PHARMA INC | $3.7M | 1.02% | 49,560 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31